Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development…
Obesity Video Recap—January 20, 2026
This biweekly Obesity video recap covers a mix of late-stage regulatory…
AI in Healthcare and Digital Health Video Recap —January 12, 2026
Here’s your AI in Healthcare and Digital Health video brief covering recent…
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A Professional…
Obesity Video Recap—January 5, 2026
This Obesity video recap highlights major Phase 3 readouts, new regulatory…
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…
Obesity Video Recap—December 9, 2025
This biweekly obesity video recap covers major GLP-1 therapeutic advances,…
Obesity Video Recap—November 25, 2025
This biweekly obesity video recap covers late-stage obesity trial readouts,…
Obesity Video Recap—November 11, 2025
This biweekly obesity video recap reviews major moves shaping the obesity and…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Obesity Today — October 28, 2025
Catch the latest obesity news, featuring industry updates, clinical progress,…